Galapagos Ratings Downgrade, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Seeking Alpha
Summary Galapagos was down on a ratings downgrade. Insmed misses Q4 EPS. Perrigo gets an approval. Galapagos Receives Rating Downgrade, Stock Skids Galapagos NV ( GLPG increased Galapagos seems to be going through critical times. The company recently reported its financial numbers and provided corporate updates. It reported signing a novel research and development agreement with Gilead Sciences and filed applications for approval of selective JAK1 inhibitor filgotinib in rheumatoid arthritis (NYSE: RA For its FY2019, the company Galapagos also provided guidance for FY2020. The company provided details about Phase 3 ISABELA program, for which it is currently recruiting candidates. The company has already enrolled over 600 patients in 2019 while it expects the futility analysis will likely be concluded in the first quarter of 2021. During 2020, the company expects to conduct over 80 clinical trials. Due to heightened research and development activities, the company reckons that its oper
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024PR Newswire
- Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock.MarketBeat
- Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
- What Makes Insmed (INSM) a Lucrative Investment? [Yahoo! Finance]Yahoo! Finance
INSM
Earnings
- 2/22/24 - Miss
INSM
Sec Filings
- 4/1/24 - Form DEFA14A
- 4/1/24 - Form DEF
- 3/11/24 - Form 8-K
- INSM's page on the SEC website